Clinical trial
Open-Label,Singel Center Study of Alefacept in Patients With Atopic Dermatitis
NCT00376129 · Insel Gruppe AG, University Hospital Bern, Other · Completed
Key facts
| NCT number | NCT00376129 |
|---|---|
| Title | Open-Label,Singel Center Study of Alefacept in Patients With Atopic Dermatitis |
| Official title | Open-Label,Singel Center Study to Evaluate the Safety and Efficacy of an Intramuskcular 12 Week-Course of Alefacept in Patients With Atopic Dermatitis |
| Lead sponsor | Insel Gruppe AG, University Hospital Bern, Other |
| Collaborators | Biogen-Dompé AG Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Atopic Dermatitis |
| Intervention type | Drug |
| Interventions | Alefacept |
| Enrollment | 10 |
| Start date | Jan 1, 2006 |
| Completion | Jan 1, 2007 |
| First posted | Sep 14, 2006 |
| Last update posted | Dec 10, 2007 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: